One in 5 of the highest-revenue drugs of 2022 was exclusively approved for rare conditions, accounting for more than 7% of US pharmaceutical spending. Study Design: Cross-sectional study. Methods: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback